Literature DB >> 17547987

Is the type of dissection in lateral neck metastasis for differentiated thyroid carcinoma important?

Sevim Turanli1.   

Abstract

OBJECTIVE: This study was to compare the types of therapeutic neck dissection in patients with differentiated thyroid carcinoma. STUDY DESIGN AND
SETTING: Sixty-one patients with lymph node metastasis in the neck, treated between 1997 and 2001, were studied retrospectively. A comparative study was made of a selective lateral neck dissection group and a radical or modified radical neck dissection group for recurrence, disease free survival (DFS), and overall survival (OS).
RESULTS: Type of dissection was not related to DFS (P=0.92), OS (P=0.33), and local recurrence ratio (P=0.56). The factors affecting local recurrence were the age over 45 years (P=0.02), tumor size (0.005), and the presence of distant metastasis (P=0.04). The factors affecting DFS and OS were tumor size (0.003), thyroid capsule invasion (0.004).
CONCLUSIONS: Determination of the type of therapeutic neck dissection depends on patient and tumor characteristics. Selective lateral neck dissection can be applied safely in selected cases.

Entities:  

Mesh:

Year:  2007        PMID: 17547987     DOI: 10.1016/j.otohns.2006.12.013

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.

Authors:  Yasuhiro Ito; Yukiko Tsushima; Hiroo Masuoka; Tomonori Yabuta; Mitsuhiro Fukushima; Hiroyuki Inoue; Chisato Tomoda; Minoru Kihara; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

3.  Thyroidectomy and lymph node dissection in papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2010-11-10

4.  The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients.

Authors:  Li-Bo Yang; Lin-Yong Sun; Yong Jiang; Ying Tang; Zhi-Hui Li; Hong-Ying Zhang; Hong Bu; Feng Ye
Journal:  Int J Endocrinol       Date:  2015-07-27       Impact factor: 3.257

5.  Risk factors for level V metastasis in patients with N1b papillary thyroid cancer.

Authors:  Jin Gu Kang; Jung Eun Choi; Su Hwan Kang
Journal:  World J Surg Oncol       Date:  2022-09-30       Impact factor: 3.253

6.  Should level V be included in lateral neck dissection in treating papillary thyroid carcinoma?

Authors:  Xiao-Jun Zhang; Dan Liu; De-Bin Xu; Ya-Qi Mu; Wen-Kuan Chen
Journal:  World J Surg Oncol       Date:  2013-11-25       Impact factor: 2.754

Review 7.  Level V Clearance in Neck Dissection for Papillary Thyroid Carcinoma: A Need for Homogeneous Studies.

Authors:  Azhar Jan Battoo; Zahoor Ahmad Sheikh; Krishnakumar Thankappan; Abdul Wahid Mir; Altaf Gowhar Haji
Journal:  Int Arch Otorhinolaryngol       Date:  2017-12-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.